Discussions concerning to the ethical issues related to stem cells have been ongoing for many years, but a special section in the latest issue of Perspectives in Biology and Medicine takes a deep look at some of the newest and most complex issues – including the direct global sales of services and untested and unproven products marketed as stem cells. Guest edited by Tamra Lysaght and Jeremy Sugarman

Quick Read

Authors, including our Jeremy Sugarman, offer a call to action, ‘Companies that develop and distribute tools for genome editing have a responsibility to construct and implement policies and procedures to protect the integrity of science, to educate their employees to make certain that all research conducted within the company adheres to the highest ethical standards’

Quick Read

In February 2016, the FDA recommended that collection of donated blood cease in areas in the United States in which ZIKV was active, unless blood testing or pathogen-reduction methods could be implemented. At the time, no vectorborne cases of ZIKV infection had been reported in the continental United States; however, an epidemic was under way in the U.S. territories, most notably in Puerto Rico and the U.S. Virgin Islands

Quick Read

An expensive screening program designed to keep the Zika virus out of the Red Cross’ blood supply has caught fewer than a dozen infected donations, a new study published Wednesday revealed. Study authors include our Jeremy Sugarman

Quick Read

Allocation of research funding for cancer and COPD is not always proportional to disease burden. “We wouldn’t want the situation to be based solely on having the loudest person’s priorities being funded; we have to take care that the needs of the less vocal as well as the least well off are taken care of”, Jeremy Sugarman said. “Governments should find ways to establish fair processes of making fair and right decisions”

Quick Read

Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins, including our Jeremy Sugarman, and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion

Quick Read

…on a global scale. Jeremy Sugarman examines ethical challenges from HIV prevention to organ transplants

Read More

The International Society for Stem Cell Research (ISSCR), the world’s largest professional organization of stem cell scientists, today released newly updated guidelines for stem cell research and the development of new clinical therapies. Guidelines Update Steering Committee includes our Jeremy Sugarman

Read More